Polymyositis Clinical Trials Polymyositis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Environmental Risk Factors for Myositis in Military Personnel
Conditions:   Dermatomyositis;   Adult Polymyositis;   Inclusion Body Myositis;   MyositisIntervention:   Sponsor:   National Institute of Environmental Health Sciences (NIEHS)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2012 Category: Research Source Type: clinical trials

Dermatomyositis and Polymyositis Registry
Conditions:   Dermatomyositis;   PolymyositisIntervention:   Drug: ActharSponsor:   Phoenix Neurological Associates, LTDRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2012 Category: Research Source Type: clinical trials

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Conditions:   Polymyositis;   DermatomyositisInterventions:   Drug: BAF312;   Drug: PlaceboSponsors:   Novartis;   Novartis PharmaceuticalsTerminated - verified June 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2010 Category: Research Source Type: clinical trials

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Conditions:   Polymyositis;   DermatomyositisInterventions:   Drug: BAF312;   Drug: PlaceboSponsors:   Novartis;   Novartis PharmaceuticalsTerminated - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2010 Category: Research Source Type: clinical trials

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Conditions:   Polymyositis;   DermatomyositisInterventions:   Drug: BAF312;   Drug: PlaceboSponsors:   Novartis;   Novartis PharmaceuticalsTerminated - verified June 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2010 Category: Research Source Type: clinical trials

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Conditions:   Polymyositis;   DermatomyositisInterventions:   Drug: BAF312;   Drug: PlaceboSponsors:   Novartis;   Novartis PharmaceuticalsCompleted - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2010 Category: Research Source Type: clinical trials

Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
Conditions:   Dermatomyositis;   PolymyositisIntervention:   Other: Active rehabilitationSponsor:   University Hospital, LilleCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2010 Category: Research Source Type: clinical trials